This week, the FDA posted a blog post about that meeting, emphasizing its "renewed unwavering commitment to the rare disease community." Advisors on FDA's Vaccines and Related Biological Products Advisory Committee are meeting on Thursday, 18 June, to discuss whether to recommend approval of Moderna's MFLUSIVA mRNA influenza vaccine for adults ages 5064 and accelerated approval for adults 65 and older
CPR, cardiopulmonary resuscitation
While most heart palpitations are benign and can be mitigated with nutritional therapy such as magnesium, it is best to schedule a visit with your physician to better understand your condition
The validated hypoallergenic cosmetics rating system: its 30-year evolution and effect on the prevalence of cosmetic reactions
These two ingredients work together to lighten these dark patches, giving your skin a more balanced and consistent appearance
If they suggest stopping semaglutide for a while, they will have a plan to manage your diabetes during that time